Review: taking Warfarin sodium and Lisinopril together


Summary

Drug interactions are reported among people who take Warfarin sodium and Lisinopril together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Lisinopril. It is created by eHealthMe based on reports of 10,759 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Warfarin sodium and Lisinopril >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 48,044 users)

Lisinopril

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. (latest outcomes from Lisinopril 102,207 users)

On Jul, 20, 2016

10,759 people who take Warfarin Sodium, Lisinopril are studied.


Number of reports submitted per year:

Warfarin sodium and Lisinopril drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 14.0% - (2 of 14 people)
  • 1 - 6 months: 54.0% - (17 of 31 people)
  • 6 - 12 months: 60.0% - (14 of 23 people)
  • 1 - 2 years: 67.0% - (27 of 40 people)
  • 2 - 5 years: 53.0% - (25 of 47 people)
  • 5 - 10 years: 91.0% - (34 of 37 people)
  • 10+ years: 85.0% - (24 of 28 people)
  • not specified: 100.0% - (3 of 3 people)
Lisinopril:
  • < 1 month: 0.0% - (0 of 10 people)
  • 1 - 6 months: 32.0% - (8 of 25 people)
  • 6 - 12 months: 50.0% - (9 of 18 people)
  • 1 - 2 years: 37.0% - (11 of 29 people)
  • 2 - 5 years: 50.0% - (33 of 65 people)
  • 5 - 10 years: 77.0% - (34 of 44 people)
  • 10+ years: 44.0% - (13 of 29 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 54.0% - (45 of 82 people)
  • male: 71.0% - (101 of 141 people)
Lisinopril:
  • female: 38.0% - (31 of 80 people)
  • male: 54.0% - (77 of 141 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 100.0% - (1 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 67.0% - (19 of 28 people)
  • 50-59: 64.0% - (34 of 53 people)
  • 60+: 66.0% - (89 of 134 people)
Lisinopril:
  • 0-1: 100.0% - (1 of 1 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 57.0% - (4 of 7 people)
  • 40-49: 53.0% - (15 of 28 people)
  • 50-59: 49.0% - (26 of 53 people)
  • 60+: 47.0% - (62 of 131 people)

Most common drug interactions over time *:

< 1 month:
  • international normalised ratio increased
  • dyspnoea
  • gastrointestinal haemorrhage
  • atrial fibrillation
  • renal failure acute
  • hypotension
  • headache
  • gastric ulcer
  • insomnia
  • anaemia
1 - 6 months:
  • international normalised ratio increased
  • proteinuria
  • dyspnoea
  • asthenia
  • cardiac failure
  • gastrointestinal haemorrhage
  • myocardial ischaemia
  • rectal haemorrhage
  • calciphylaxis
  • fatigue
6 - 12 months:
  • gastrointestinal haemorrhage
  • fatigue
  • international normalised ratio increased
  • cerebrovascular accident
  • dehydration
  • diarrhoea
  • nausea
  • anaemia
  • febrile neutropenia
  • haematemesis
1 - 2 years:
  • depression
  • hypertension
  • anxiety
  • cardiac failure congestive
  • congestive cardiomyopathy
  • nightmare
  • dizziness
  • international normalised ratio increased
  • dyspepsia
  • fatigue
2 - 5 years:
  • anxiety
  • depression
  • cerebrovascular accident
  • infection
  • loose tooth
  • osteonecrosis
  • blood disorder
  • impaired healing
  • angioedema
  • cardiac disorder
5 - 10 years:
  • dizziness
  • hypotension
  • depression
  • fatigue
  • oedema peripheral
  • lip swelling
  • oedema genital
  • diarrhoea
  • cerebrovascular accident
  • confusional state
10+ years:
  • renal failure acute
  • mental status changes
  • bradycardia
  • international normalised ratio increased
  • dizziness
  • atrial fibrillation
  • chest pain
  • gingival bleeding
  • haemoglobin decreased
  • occult blood positive
not specified:
  • pain
  • cardiac failure congestive
  • atrial fibrillation
  • dyspnoea
  • anxiety
  • nausea
  • international normalised ratio increased
  • fatigue
  • dizziness
  • asthenia

Most common drug interactions by gender *:

female:
  • pain
  • atrial fibrillation
  • anxiety
  • cardiac failure congestive
  • nausea
  • dyspnoea
  • asthenia
  • fatigue
  • fall
  • diarrhoea
male:
  • pain
  • cardiac failure congestive
  • dyspnoea
  • atrial fibrillation
  • international normalised ratio increased
  • anxiety
  • nausea
  • dizziness
  • fatigue
  • injury

Most common drug interactions by age *:

0-1:
  • muscular weakness
  • tremor
  • cerebrovascular accident
  • endocarditis
  • heart racing
  • neoplasm malignant
  • prothrombin level increased
  • rash
  • reaction to azo-dyes
  • tolerance increased
2-9:
  • ageusia
  • anosmia
10-19:
  • cardiac failure congestive
  • nausea
  • vomiting
  • decreased appetite
  • mitral valve incompetence
  • tachycardia
  • aortic valve incompetence
  • atrial fibrillation
  • blood pressure decreased
  • dysuria
20-29:
  • cardiac failure congestive
  • bronchitis
  • influenza like illness
  • tuberculin test positive
  • urinary tract infection
  • presyncope
  • cholecystitis
  • lobar pneumonia
  • atrial fibrillation
  • intracardiac thrombus
30-39:
  • nausea
  • anxiety
  • vomiting
  • hypoaesthesia
  • headache
  • pain
  • pulmonary embolism
  • abdominal pain
  • depression
  • tremor
40-49:
  • pain
  • atrial fibrillation
  • fatigue
  • hypotension
  • nausea
  • cardiac failure congestive
  • international normalised ratio increased
  • anxiety
  • dizziness
  • dyspnoea
50-59:
  • pain
  • anxiety
  • oedema peripheral
  • dyspnoea
  • cardiac failure congestive
  • atrial fibrillation
  • fatigue
  • nausea
  • emotional distress
  • injury
60+:
  • pain
  • atrial fibrillation
  • cardiac failure congestive
  • dyspnoea
  • international normalised ratio increased
  • nausea
  • asthenia
  • anxiety
  • dizziness
  • fatigue

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Lisinopril?

Can you answer these questions?

More questions for: Warfarin sodium, Lisinopril

You may be interested in these reviews

More reviews for: Warfarin sodium, Lisinopril

On eHealthMe, Warfarin sodium (warfarin) is often used to treat atrial fibrillation/flutter. Lisinopril (lisinopril) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.